{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T23:59:24Z","timestamp":1781913564046,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"NIH","award":["U01-AI082229"],"award-info":[{"award-number":["U01-AI082229"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12879-018-3013-0","type":"journal-article","created":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T04:06:07Z","timestamp":1519963567000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Cost analysis of rapid diagnostics for drug-resistant tuberculosis"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6239-1965","authenticated-orcid":false,"given":"Erik J.","family":"Groessl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore G.","family":"Ganiats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Hillery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Trollip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta L.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald G.","family":"Catanzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy C.","family":"Rodwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S.","family":"Garfein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeriu","family":"Crudu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Victor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Catanzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,2]]},"reference":[{"key":"3013_CR1","volume-title":"Global tuberculosis report 2013","author":"World Health Organization (WHO)","year":"2013","unstructured":"World Health Organization (WHO): Global tuberculosis report 2013. 2013."},{"issue":"4","key":"3013_CR2","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1164\/rccm.167.4.603","volume":"167","author":"HM Blumberg","year":"2003","unstructured":"Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, Fujiwara P, Grzemska M, Hopewell PC, Iseman MD, et al. American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med. 2003;167(4):603\u201362.","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"3013_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015735","volume":"5","author":"JR Andrews","year":"2010","unstructured":"Andrews JR, Shah NS, Weissman D, Moll AP, Friedland G, Gandhi NR. Predictors of multidrug- and extensively drug-resistant tuberculosis in a high HIV prevalence community. PLoS One. 2010;5(12):e15735.","journal-title":"PLoS One"},{"issue":"9","key":"3013_CR4","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.5588\/ijtld.13.0834","volume":"18","author":"AS Dharmadhikari","year":"2014","unstructured":"Dharmadhikari AS, Mphahlele M, Venter K, Stoltz A, Mathebula R, Masotla T, van der Walt M, Pagano M, Jensen P, Nardell E. Rapid impact of effective treatment on transmission of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2014;18(9):1019\u201325.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"6","key":"3013_CR5","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1128\/JCM.06664-11","volume":"50","author":"A Engstrom","year":"2012","unstructured":"Engstrom A, Morcillo N, Imperiale B, Hoffner SE, Jureen P. Detection of first- and second-line drug resistance in mycobacterium tuberculosis clinical isolates by pyrosequencing. J Clin Microbiol. 2012;50(6):2026\u201333.","journal-title":"J Clin Microbiol"},{"issue":"Suppl 2","key":"3013_CR6","doi-asserted-by":"publisher","first-page":"S147","DOI":"10.1093\/infdis\/jir860","volume":"205","author":"R McNerney","year":"2012","unstructured":"McNerney R, Maeurer M, Abubakar I, Marais B, McHugh TD, Ford N, Weyer K, Lawn S, Grobusch MP, Memish Z, et al. Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities. J Infect Dis. 2012;205(Suppl 2):S147\u201358.","journal-title":"J Infect Dis"},{"issue":"1","key":"3013_CR7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1093\/bmb\/ldu011","volume":"110","author":"M Toosky","year":"2014","unstructured":"Toosky M, Javid B. Novel diagnostics and therapeutics for drug-resistant tuberculosis. Br Med Bull. 2014;110(1):129\u201340.","journal-title":"Br Med Bull"},{"issue":"8","key":"3013_CR8","doi-asserted-by":"publisher","first-page":"e0136861","DOI":"10.1371\/journal.pone.0136861","volume":"10","author":"A Catanzaro","year":"2015","unstructured":"Catanzaro A, Rodwell TC, Catanzaro DG, Garfein RS, Jackson RL, Seifert M, Georghiou SB, Trollip A, Groessl E, Hillery N, et al. Performance comparison of three rapid tests for the diagnosis of drug-resistant tuberculosis. PLoS One. 2015;10(8):e0136861.","journal-title":"PLoS One"},{"issue":"1","key":"3013_CR9","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1186\/1745-6215-15-434","volume":"15","author":"N Hillery","year":"2014","unstructured":"Hillery N, Groessl EJ, Trollip A, Catanzaro D, Jackson L, Rodwell TC, Garfein RS, Lin SY, Eisenach K, Ganiats TG, et al. The global consortium for drug-resistant tuberculosis diagnostics (GCDD): design of a multi-site, head-to-head study of three rapid tests to detect extensively drug-resistant tuberculosis. Trials. 2014;15(1):434.","journal-title":"Trials"},{"issue":"9776","key":"3013_CR10","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/S0140-6736(11)60438-8","volume":"377","author":"CC Boehme","year":"2011","unstructured":"Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, Tahirli R, Gler MT, Blakemore R, Worodria W, Gray C, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB\/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet. 2011;377(9776):1495\u2013505.","journal-title":"Lancet"},{"issue":"7","key":"3013_CR11","doi-asserted-by":"publisher","first-page":"e69267","DOI":"10.1371\/journal.pone.0069267","volume":"8","author":"Y Pang","year":"2013","unstructured":"Pang Y, Li Q, Ou X, Sohn H, Zhang Z, Li J, Xia H, Kam KM, O'Brien RJ, Chi J, et al. Cost-effectiveness comparison of Genechip and conventional drug susceptibility test for detecting multidrug-resistant tuberculosis in China. PLoS One. 2013;8(7):e69267.","journal-title":"PLoS One"},{"issue":"3","key":"3013_CR12","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1183\/09031936.00147912","volume":"42","author":"A Pantoja","year":"2013","unstructured":"Pantoja A, Fitzpatrick C, Vassall A, Weyer K, Floyd K. Xpert MTB\/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysis. Eur Respir J. 2013;42(3):708\u201320.","journal-title":"Eur Respir J"},{"issue":"6","key":"3013_CR13","doi-asserted-by":"publisher","first-page":"647","DOI":"10.5588\/ijtld.13.0776","volume":"18","author":"DW Dowdy","year":"2014","unstructured":"Dowdy DW, van't Hoog A, Shah M, Cobelens F. Cost-effectiveness of rapid susceptibility testing against second-line drugs for tuberculosis. Int J Tuberc Lung Dis. 2014;18(6):647\u201354.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"9","key":"3013_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007129","volume":"4","author":"Y Balabanova","year":"2009","unstructured":"Balabanova Y, Drobniewski F, Nikolayevskyy V, Kruuner A, Malomanova N, Simak T, Ilyina N, Zakharova S, Lebedeva N, Alexander HL, et al. An integrated approach to rapid diagnosis of tuberculosis and multidrug resistance using liquid culture and molecular methods in Russia. PLoS One. 2009;4(9):e7129.","journal-title":"PLoS One"},{"issue":"12","key":"3013_CR15","first-page":"1449","volume":"12","author":"C Rodrigues","year":"2008","unstructured":"Rodrigues C, Jani J, Shenai S, Thakkar P, Siddiqi S, Mehta A. Drug susceptibility testing of mycobacterium tuberculosis against second-line drugs using the Bactec MGIT 960 system. Int J Tuberc Lung Dis. 2008;12(12):1449\u201355.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"12","key":"3013_CR16","doi-asserted-by":"publisher","first-page":"e152","DOI":"10.1086\/374931","volume":"36","author":"D Almeida","year":"2003","unstructured":"Almeida D, Rodrigues C, Udwadia ZF, Lalvani A, Gothi GD, Mehta P, Mehta A. Incidence of multidrug-resistant tuberculosis in urban and rural India and implications for prevention. Clin Infect Dis. 2003;36(12):e152\u20134.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"3013_CR17","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1183\/09031936.00111812","volume":"42","author":"HE Jenkins","year":"2013","unstructured":"Jenkins HE, Plesca V, Ciobanu A, Crudu V, Galusca I, Soltan V, Serbulenco A, Zignol M, Dadu A, Dara M, et al. Assessing spatial heterogeneity of multidrug-resistant tuberculosis in a high-burden country. Eur Respir J. 2013;42(5):1291\u2013301.","journal-title":"Eur Respir J"},{"key":"3013_CR18","unstructured":"Useful Lives Table. Office of the Controller. Chicago: Northwestern University; 2013. http:\/\/www.northwestern.edu\/controller\/accounting-services\/equipment-inventory\/docs\/useful-lives-table.xls . Accessed July 2013."},{"issue":"11 Suppl","key":"3013_CR19","first-page":"NS50","volume":"30","author":"EA Latimer","year":"1992","unstructured":"Latimer EA, Becker ER. Incorporating practice costs into the resource-based relative value scale. Med Care. 1992;30(11 Suppl):NS50\u201360.","journal-title":"Med Care"},{"key":"3013_CR20","volume-title":"Practice expenses under the Medicare fee schedule: a resource-based approach","author":"Physician Payment Review Commission","year":"1992","unstructured":"Physician Payment Review Commission. Practice expenses under the Medicare fee schedule: a resource-based approach. Washington, DC: Physician Payment Review Commission; 1992."},{"issue":"6","key":"3013_CR21","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1123\/jpah.6.6.767","volume":"6","author":"EJ Groessl","year":"2009","unstructured":"Groessl EJ, Kaplan RM, Blair SN, Rejeski WJ, Katula JA, King AC, Fielding RA, Glynn NW, Pahor M. A cost analysis of a physical activity intervention for older adults. J Phys Act Health. 2009;6(6):767\u201374.","journal-title":"J Phys Act Health"},{"issue":"1","key":"3013_CR22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.2337\/diacare.26.1.36","volume":"26","author":"WH Herman","year":"2003","unstructured":"Herman WH, Brandle M, Zhang P, Williamson DF, Matulik MJ, Ratner RE, Lachin JM, Engelgau MM. Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program. Diabetes Care. 2003;26(1):36\u201347.","journal-title":"Diabetes Care"},{"key":"3013_CR23","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780195108248.001.0001","volume-title":"Cost-effectiveness in health and medicine","author":"MR Gold","year":"1996","unstructured":"Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine. New York, NY: Oxford University Press; 1996."},{"key":"3013_CR24","doi-asserted-by":"crossref","unstructured":"Catanzaro A, Rodwell TC, Catanzaro DG, Garfein RS, Jackson RL, Seifert M, Georghiou SB, Trollip A, Groessl EG, Hillery N, et al. Performance comparison of three rapid tests for the diagnosis of drug-resistant tuberculosis. PLoS One. in press;","DOI":"10.1371\/journal.pone.0136861"},{"key":"3013_CR25","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/1471-2334-9-139","volume":"9","author":"S Ogwang","year":"2009","unstructured":"Ogwang S, Asiimwe BB, Traore H, Mumbowa F, Okwera A, Eisenach KD, Kayes S, Jones-Lopez EC, McNerney R, Worodria W, et al. Comparison of rapid tests for detection of rifampicin-resistant mycobacterium tuberculosis in Kampala, Uganda. BMC Infect Dis. 2009;9:139.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"3013_CR26","doi-asserted-by":"publisher","first-page":"e54587","DOI":"10.1371\/journal.pone.0054587","volume":"8","author":"A Pooran","year":"2013","unstructured":"Pooran A, Pieterson E, Davids M, Theron G, Dheda K. What is the cost of diagnosis and management of drug resistant tuberculosis in South Africa? PLoS One. 2013;8(1):e54587.","journal-title":"PLoS One"},{"key":"3013_CR27","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1186\/1471-2334-13-352","volume":"13","author":"M Shah","year":"2013","unstructured":"Shah M, Chihota V, Coetzee G, Churchyard G, Dorman SE. Comparison of laboratory costs of rapid molecular tests and conventional diagnostics for detection of tuberculosis and drug-resistant tuberculosis in South Africa. BMC Infect Dis. 2013;13:352.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"3013_CR28","doi-asserted-by":"publisher","first-page":"16","DOI":"10.5588\/ijtld.10.0065","volume":"16","author":"E Leung","year":"2012","unstructured":"Leung E, Minion J, Benedetti A, Pai M, Menzies D. Microcolony culture techniques for tuberculosis diagnosis: a systematic review. Int J Tuberc Lung Dis. 2012;16(1):16\u201323. i-iii","journal-title":"Int J Tuberc Lung Dis"},{"issue":"15","key":"3013_CR29","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1056\/NEJMoa055524","volume":"355","author":"DA Moore","year":"2006","unstructured":"Moore DA, Evans CA, Gilman RH, Caviedes L, Coronel J, Vivar A, Sanchez E, Pinedo Y, Saravia JC, Salazar C, et al. Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med. 2006;355(15):1539\u201350.","journal-title":"N Engl J Med"},{"issue":"3","key":"3013_CR30","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1590\/S1726-46342011000300004","volume":"28","author":"L Solari","year":"2011","unstructured":"Solari L, Gutierrez A, Suarez C, Jave O, Castillo E, Yale G, Ascencios L, Quispe N, Valencia E, Suarez V. Cost analysis of rapid methods for diagnosis of multidrug resistant tuberculosis in different epidemiologic groups in Peru. Revista peruana de medicina experimental y salud publica. 2011;28(3):426\u201331.","journal-title":"Revista peruana de medicina experimental y salud publica"},{"key":"3013_CR31","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1186\/s12879-016-1781-y","volume":"16","author":"SB Georghiou","year":"2016","unstructured":"Georghiou SB, Seifert M, Lin SY, Catanzaro D, Garfein RS, Jackson RL, Crudu V, Rodrigues C, Victor TC, Catanzaro A, et al. Shedding light on the performance of a pyrosequencing assay for drug-resistant tuberculosis diagnosis. BMC Infect Dis. 2016;16:458.","journal-title":"BMC Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3013-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T18:06:24Z","timestamp":1719857184000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-018-3013-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,2]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3013"],"URL":"https:\/\/doi.org\/10.1186\/s12879-018-3013-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,2]]},"assertion":[{"value":"1 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was registered with(#NCT02170441) and was reviewed and approved by an academic Human Research Protection Program and each of the study sites. The primary IRB was approved at University of California San Diego Human Research Protection Program. Participation did not include any changes to the standard of care. All study participants or their legal guardian\/representative provided written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"102"}}